← Back to Search

Contact us first for Health Behaviors

N/A
Waitlist Available
Led By Amir Goren, PhD
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up in the 30 days following the appointment
Awards & highlights

Study Summary

This trial aims to reduce ED visits by providing more info on when to go to ED, contact Geisinger, or find nearby ConvenientCare. They'll A/B test different versions of the After Visit Summary to assess effectiveness.

Eligible Conditions
  • Health Behaviors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~in the 30 days following the appointment
This trial's timeline: 3 weeks for screening, Varies for treatment, and in the 30 days following the appointment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Inappropriate ED visits
Other outcome measures
Calls
Patient portal messages
Urgent care visits

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Contact us first + urgent care map + self-triageExperimental Treatment3 Interventions
Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. This arm will also receive a self-triage chart, with common reasons patients go to the ED and situations where seeking alternative care might be appropriate.
Group II: Contact us first + urgent care mapExperimental Treatment2 Interventions
Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care.
Group III: Contact us firstExperimental Treatment1 Intervention
Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention.
Group IV: Standard practiceActive Control1 Intervention
Patients in this arm will receive the current standard practice AVS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contact information
2023
N/A
~239850
Urgent care map
2023
N/A
~239850
Self-triage chart
2023
N/A
~239850

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
148 Previous Clinical Trials
1,646,252 Total Patients Enrolled
10 Trials studying Health Behaviors
472,877 Patients Enrolled for Health Behaviors
Amir Goren, PhDPrincipal InvestigatorGeisinger Clinic
20 Previous Clinical Trials
291,880 Total Patients Enrolled
4 Trials studying Health Behaviors
118,690 Patients Enrolled for Health Behaviors

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to volunteer for this experiment?

"As indicated on clinicaltrials.gov, this trial posted March 1st of 2023 and has since stopped recruiting patients; however, there are 277 other trials actively enrolling candidates at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options
Amir Goren 2023. "Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05787548.
~119920 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top